Charting a Bold Path for 2025
Exciting times are ahead for Camber Pharmaceuticals in 2025!
We are on track to launch up to 55 new generic medications, including several Day-One products, specialty drugs, and over-the-counter (OTC) medications. Additionally, we are continuing our investment in portfolio expansion, critical infrastructure, and associate development to create an even more significant impact.
To learn more, please watch this short message from Camber’s management team!
Recent articles
- Now Available from Camber: Topiramate Extended-Release Capsules, USP
- New Product Launch: Clomiphene Citrate Tablets, USP
- Camber Launches Raltegravir Tablets 400 mg
- Specialty Generics: Where Access Meets Affordability
- Buprenorphine and Naloxone Sublingual Films Added to Portfolio
- Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio